KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 132 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $78,000 | +1.3% | 10,934 | +2.3% | 0.00% | – |
| Q2 2017 | $77,000 | +16.7% | 10,684 | 0.0% | 0.00% | – |
| Q1 2017 | $66,000 | +4.8% | 10,684 | 0.0% | 0.00% | – |
| Q4 2016 | $63,000 | +10.5% | 10,684 | 0.0% | 0.00% | – |
| Q3 2016 | $57,000 | -35.2% | 10,684 | -20.0% | 0.00% | -100.0% |
| Q2 2016 | $88,000 | +41.9% | 13,358 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $62,000 | +19.2% | 13,358 | +29.9% | 0.00% | – |
| Q4 2015 | $52,000 | -10.3% | 10,284 | -37.2% | 0.00% | -100.0% |
| Q3 2015 | $58,000 | – | 16,384 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Old West Investment Management, LLC | 1,068,719 | $3,633,000 | 1.50% |
| Abrams Capital Management | 9,108,867 | $30,970,000 | 0.82% |
| Baupost Group | 25,791,678 | $87,692,000 | 0.67% |
| Bristol Advisors, LLC | 51,100 | $174,000 | 0.29% |
| RICE HALL JAMES & ASSOCIATES, LLC | 2,228,059 | $7,575,000 | 0.27% |
| NEXTHERA CAPITAL LP | 200,000 | $680,000 | 0.13% |
| LINCOLN CAPITAL CORP | 37,280 | $127,000 | 0.10% |
| Meridian Wealth Management, LLC | 49,600 | $169,000 | 0.07% |
| Rubric Capital Management LP | 199,883 | $680,000 | 0.07% |
| Virtus ETF Advisers LLC | 155,009 | $527,000 | 0.05% |